Drug Delivery Partnering Terms and Agreements in Pharma and Biotech, 2nd editionCurrent Partnering
November 1, 2010
408 Pages - SKU: WWV2873682
Additional InformationKey benefits
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech provides the reader with the following key benefits:
- In-depth understanding of drug delivery deal trends since 2000
- Analysis of the structure of drug delivery agreements with numerous real life case studies
- Comprehensive access to over 900 actual drug delivery contracts entered into by the world’s biopharma companies
- Detailed access to actual drug delivery contracts enter into by the leading fifty bigpharma companies
- Insight into the terms included in a drug delivery agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech is intended to provide the reader with an in-depth understanding of the drug delivery trends and structure of deals entered into by leading companies worldwide.
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech includes:
- Trends in drug delivery dealmaking in the biopharma industry since 2000
- Analysis of drug delivery deal structure
- Case studies of real-life drug delivery deals
- Access to over 900 drug delivery contract documents
- The leading drug delivery deals by value since 2000
- Most active drug delivery dealmakers since 2000
- The leading drug delivery partnering resources
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
The Drug Delivery Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive access to available contract documents for over 900 drug delivery deals. Analyzing actual contract agreements allows assessment of the following:
- What are the precise drug delivery rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
We can help you find what you need. Call us or write us:
Need help in your search?
Drug Delivery Reports
- Global Smart Pill Technology Market 2012 2016
- Drug Delivery: Surveying the Global Competitive Landscape
- The World Market for Implantable and Needle-Free Drug Delivery Systems
- Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
- Portugal Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018